via uc.edu
UC scientist patented treatment for stubborn pathogens
There may be a solution on the horizon to combating superbug infections resistant to antibiotics. The tenacious bacteria and fungi sicken more than 2.8 million people and lead to more than 35,000 deaths in the United States each year.
An international team of researchers has found that a combination of ingredients (acidified nitrite and ethylenediaminetetraacetic acid) known as AB569 and developed by a University of Cincinnati scientist kills a bacteria (Pseudomonas aeruginosa), one of the most serious pathogens that exhibits multidrug resistance and virulence.
Their findings are available online in the scholarly journal of the Proceedings of the National Academy of Sciences of the United States of America.
“AB569 kills these pathogenic bacteria by targeting their DNA, RNA and protein biosynthesis as well as energy and iron metabolism at concentrations that do not harm human cells,” explains Daniel Hassett, a professor in the UC Department of Molecular Genetics, Biochemistry and Microbiology. “These were tested in laboratory mice with humanized cells. Our data implicate that AB569 is a safe and effective means that could be applied to eradicate these superbugs.”
Pseudomonas aeruginosa was applied to the lungs of laboratory mice for five days. This pathogen in humans causes pulmonary infections in patients with cystic fibrosis and chronic obstructive pulmonary disease and many other opportunistic infections. Pseudomonas aeruginosa is considered one of six ESKAPE pathogens, known by their acronym and considered among the most resistant and deadly to humans.
The ESKAPE pathogens include Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. These ESKAPE pathogens typically result in hospital-acquired infections leading to illness such as pneumonia and MRSA infections. Urinary tract infections that are resistant to antibiotics are also among illnesses caused by these organisms.
These superbugs have an ingenious mechanism of being able to resist traditional antibiotic therapies by a vast number of acquired strategies. Antibiotics affect specific processes in the bacteria, but not all of them. AB569 affects multiple processes at once leaving the exposed bacteria simply overwhelmed.
Daniel Hassett, professor UC College of Medicine
“These superbugs have an ingenious mechanism of being able to resist traditional antibiotic therapies by a vast number of acquired strategies,” explains Hassett, also the paper’s senior author. “Antibiotics affect specific processes in the bacteria, but not all of them. AB569 affects multiple processes at once leaving the exposed bacteria simply overwhelmed.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
AB569
- USA Track & Field expands maternity policy
USA Track & Field unveiled a program Thursday that expands an existing maternity support system to give athletes more time to return. Olympic hurdler Christina Clemons was instrumental in pushing for ...
- Sports briefs: Free clinic for new and returning baseball umpires coming May 4
A free clinic for new and returning baseball umpires is taking place on May 4 from 8:30 a.m. to noon at Holy Cross Catholic Secondary School sponsored by the Kawartha ...
- AllianceBernstein Holding LP AB
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
- AllianceBernstein Holding L.P.
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
- Day 2 of Trump New York hush money trial
Our live coverage has concluded. Please scroll through the posts below to learn about the second day of Trump's trial in New York. Prosecutors said they don't have any challenges for cause for the ...
Go deeper with Google Headlines on:
AB569
[google_news title=”” keyword=”AB569″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Superbugs
- 'Just in case' antibiotics widely overused during COVID-19, says UN health agency
Antibiotics saw 'extensive overuse' globally among hospitalised COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially increasing the already serious and ...
- New UTI vaccine wards off infection for years, early studies suggest
More than 50% of the patients who used a new mouth-spray-based vaccine didn't have a UTI for up to nine years.
- BHP’s move for Anglo signals fierce battle for resources vital to green transition
The yen hit a 34-year low after the Bank of Japan held interest rates near zero despite rising pressure on the central bank to tighten its policy and prop up the currency. The BoJ ended its negative ...
- Superbugs could lower your life expectancy by nearly 2 years, report says. What to know about antimicrobial resistance
Uncontrolled AMR is also projected to cost the world $855 billion annually until 2035, international leaders say.
- Researcher discusses importance of communicating to the public during a pandemic, and the personal risk it can entail
In global crises like the COVID-19 pandemic, it is vital that scientists step forward to engage with the public and help deliver medical and scientific advice in a friendly, digestible and open format ...
Go deeper with Google Headlines on:
Superbugs
[google_news title=”” keyword=”superbugs” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]